What the Covid Resurgence Could Mean for Stocks

It was another wild trading session this morning as stocks opened significantly lower on the day.

November 24, 2021 12:48PM Let This Find Your Next Trade - FAST The hardest part of trading is analyzing all the charts to find your next trade. It can take hours... OR You can simply activate my unusual "trading engine" on your computer, tablet, or smartphone... ...and let it find your next trade in just a few seconds. PLUS, risk management is built-in to the trading rules, so you don't need to think too much. Go here to try it out... What the Covid Resurgence Could Mean for Stocks It was another wild trading session this morning as stocks opened significantly lower on the day. Treasury yields initially spiked, driving equities lower. The 10-year Treasury yield hit a 6-month high for a few moments. But several hours later, yields were back down. Rate-sensitive tech shares gained, helping to lift the S&P. Dow components sat at a loss. Despite this morning’s growth-led intraday reversal, however, many analysts still believe value shares will outperform in the coming months. “It’s certainly a story of more rotation,” explained Rob Haworth, senior investment strategist at U.S. Bank Wealth Management. “The market is now, with the Powell renomination, thinking this is a reopening story, which sets aside any of the risks or concerns we might have about rising Covid infection rates.” Haworth’s comments were made prior to a surprise announcement from the Slovakian government, which is set to impose a 2-week lockdown on its citizens regardless of vaccine status. The country is experiencing the world’s fastest rise in infections when adjusted for population. Neighboring countries Hungary and the Czech Republic also saw record-setting increases in daily infections yesterday. Last weekend, Austria entered a nationwide lockdown as well. Germany attempted to curb new infections also by placing additional restrictions on the unvaccinated. (...continued below...) BREAKING: BUY ALERT JUST ISSUED Heads up -- this brand new buy alert was just issued. This is a time-sensitive alert, so it's urgent you see it today. This is a really unique trade. Don't miss this one! Click to get in on this trade... Will these lockdowns really help to “set aside any of the risks or concerns” about a Covid resurgence? Not at all. Case totals are rising even in the United States. Deaths are up, too. In fact, US Covid deaths this year have actually exceeded 2020’s total based on data from Johns Hopkins. It’s a bit surprising given that over 60% of the US population is fully vaccinated according to the CDC. 69% are at least partially vaccinated. Yet deaths in 2021 are higher than before the US had access to Covid vaccines. Worse still is that we have another month to go before the year ends. If infections continue to accelerate stateside, deaths could surge through Christmas. And for the most part, analysts didn’t think that Covid would make a comeback. They believed that vaccines, treatment methods, and social distancing would finally end the pandemic in the near future. Now, it’s clear that Covid’s sticking around for at least a little while longer than expected. Wall Street banks said last month that a new variant could spoil the fun in 2022, but none of them predicted a good, old-fashioned seasonal spike in cases. It’s already begun in Europe, and even in highly vaccinated countries. (...continued below...) "Crypto Nerd": Don't Buy Bitcoin - Buy THIS Instead This reclusive "crypto nerd" known for his uncanny ability to spot the hottest growth trends in crypto recently revealed the name and ticker symbol of one of his top buys for the next 12 months. It's part of a new "next gen" crypto wave that he believes is much more important - and potentially much more lucrative than Bitcoin. Go here for all the details. What happens if the US experiences something similar? It won’t be pretty for reopening-sensitive stocks. And though growth shares won’t get hurt as much, they also won’t enjoy a “pandemic reboot” by any means. The Fed’s committed to slowly whittling away at its bond-buying programs. Inflation is surging and at least one rate hike seems likely next year. If Covid cases continue climbing, the Fed will be put in an even more difficult position. Remaining hawkish into the teeth of an infection resurgence could have dire economic consequences. Alternatively, going dovish could push inflation to dizzying heights. We’ve talked for months about the Fed’s “damned if you do, damned if you don’t” predicament. Powell was facing a tough situation six months ago. Now, escaping unscathed will be darn near impossible. Unless, of course, the world simply chooses to live with Covid rather than avoid it at all costs. But based on the new lockdowns out of Europe, that outcome seems highly unlikely if not completely out of the question. #1 Options Trading "Secret Weapon" Our co-founder invented this "secret weapon"... ...that automatically analyzes every single option available for a "short list" of stocks every single day. You just click a button... ...and it scans thousands of options and spits out the specific ones that meet its strict requirements. We set up this web page where you can learn more about this "secret weapon" and also take it for a "test drive". Go here to try it out... You are receiving this email because you opted in at one of the Profits Run websites. Our office hours are Monday - Friday 9AM - 5PM EST 28339 Beck Rd Suite F6, Wixom, MI 48393 Phone: (248) 733-4343 / Email: support@profitsrun.com Privacy Policy | Terms & Conditions | Disclaimer Copyright © Profits Run, Inc. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from the publisher. Profits Run is a research publishing firm. The information we publish is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. It is not designed to meet your personal situation - we are not financial advisors nor do we give personalized advice. The opinions expressed herein are those of the publisher and are subject to change without notice. Published content may become outdated and there is no obligation to update any such information. Recommendations in Profits Run publications should be made only after consulting with your financial advisor and only after reviewing the prospectus or financial statements of the company in question. You shouldn't make any decision based solely on what you read here. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice.

Unsubscribe

If you wish to stop receiving our emails or change your subscription options, please Manage Your Subscription
Profits Run, Inc., 28339 Beck Rd, Suite F6, Wixom, MI 48393